HK1198010B - A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis - Google Patents
A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis Download PDFInfo
- Publication number
- HK1198010B HK1198010B HK14111720.8A HK14111720A HK1198010B HK 1198010 B HK1198010 B HK 1198010B HK 14111720 A HK14111720 A HK 14111720A HK 1198010 B HK1198010 B HK 1198010B
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- formulation
- formula
- composition
- tablets
- Prior art date
Links
Claims (2)
- Verbindung mit der Formel I: oder pharmazeutisch unbedenkliches Salz davon zur Verwendung beim Behandeln von Glomerulosklerose.
- Verwendung einer Verbindung mit der Formel I: oder eines pharmazeutisch unbedenklichen Salzes davon beim Herstellen eines Arzneimittels zum Behandeln von Glomerulosklerose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US165419P | 2009-03-31 | ||
| US165447P | 2009-03-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18104154.4A Division HK1244687B (en) | 2009-03-31 | 2014-11-20 | A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis and iga-induced nephropathy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18104154.4A Addition HK1244687B (en) | 2009-03-31 | 2014-11-20 | A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis and iga-induced nephropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1198010A HK1198010A (en) | 2015-03-06 |
| HK1198010B true HK1198010B (en) | 2018-04-20 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9993461B2 (en) | Method for treating disorders associated with glomerular function | |
| EP3525784B1 (de) | Sparsentan pour son utilisation dans le traitement du syndrome d'alport | |
| CN118791463A (zh) | 取代的吡唑并哌啶羧酸 | |
| TW202139996A (zh) | 治療apol-1依賴性局灶性節段性腎小球硬化之方法 | |
| CN111225917A (zh) | 取代咪唑并吡啶酰胺及其用途 | |
| CA3124127A1 (en) | Amorphous sparsentan compositions | |
| EP2001446A2 (de) | Sitaxsentan-natrium-formulierungen | |
| CN102153538B (zh) | 苯并环衍生物 | |
| HK1198010B (en) | A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis | |
| HK1244687B (en) | A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis and iga-induced nephropathy | |
| HK1198010A (en) | A biphenylsulfonamide endothelin and angiotensin ii receptor antagonist to treat glomerulosclerosis | |
| HK40118187A (zh) | 取代的吡唑并哌啶羧酸 | |
| HK40118186A (zh) | 取代的吡唑并哌啶羧酸 | |
| HK40091213A (zh) | 取代的吡唑并哌啶羧酸 | |
| US8476307B2 (en) | Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof | |
| HK40073287B (zh) | 取代的吡唑并哌啶羧酸 | |
| EA049460B1 (ru) | Замещенные пиразолопиперидинкарбоновые кислоты | |
| US20050176798A1 (en) | Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof | |
| HK40021283A (en) | Substituted imidazopyridine amides and use thereof |